Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Male breast cancer is a rare disease, accounting for only 1% of breast cancer diagnoses in
the USA. The current literature suggests that genetic factors including BRCA2 mutations …

Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has
increased over the past 25years. The rarity of this entity precludes prospective randomized …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Male breast cancer is a rare disease for which treatment has been based on the evidence
available from female breast cancer. The new genomic tools can better characterize the …